BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27156629)

  • 21. CRISPRi repression of nonhomologous end-joining for enhanced genome engineering via homologous recombination in Yarrowia lipolytica.
    Schwartz C; Frogue K; Ramesh A; Misa J; Wheeldon I
    Biotechnol Bioeng; 2017 Dec; 114(12):2896-2906. PubMed ID: 28832943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The zebrafish genome editing toolkit.
    Ata H; Clark KJ; Ekker SC
    Methods Cell Biol; 2016; 135():149-70. PubMed ID: 27443924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic genome engineering via CRISPR-Cas systems.
    Moreno AM; Mali P
    Wiley Interdiscip Rev Syst Biol Med; 2017 Jul; 9(4):. PubMed ID: 28198142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
    Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
    FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome editing comes of age.
    Kim JS
    Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visualization analysis of CRISPR/Cas9 gene editing technology studies.
    Du QS; Cui J; Zhang CJ; He K
    J Zhejiang Univ Sci B; 2016 Oct.; 17(10):798-806. PubMed ID: 27704749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilization of CRISPR Interference To Validate MmpL3 as a Drug Target in
    McNeil MB; Cook GM
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic Genome Editing Goes Viral.
    Zafra MP; Dow LE
    Trends Mol Med; 2016 Oct; 22(10):831-833. PubMed ID: 27555346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis.
    McNeil MB; Keighley LM; Cook JR; Cheung CY; Cook GM
    Mol Microbiol; 2021 Oct; 116(4):1033-1043. PubMed ID: 34346123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a fast and easy method for Escherichia coli genome editing with CRISPR/Cas9.
    Zhao D; Yuan S; Xiong B; Sun H; Ye L; Li J; Zhang X; Bi C
    Microb Cell Fact; 2016 Dec; 15(1):205. PubMed ID: 27908280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly efficient heritable plant genome engineering using Cas9 orthologues from Streptococcus thermophilus and Staphylococcus aureus.
    Steinert J; Schiml S; Fauser F; Puchta H
    Plant J; 2015 Dec; 84(6):1295-305. PubMed ID: 26576927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Efficiency Genome Editing of Streptomyces Species by an Engineered CRISPR/Cas System.
    Wang Y; Cobb RE; Zhao H
    Methods Enzymol; 2016; 575():271-84. PubMed ID: 27417933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The application of CRISPR/Cas9 in genome editing of filamentous fungi.
    Li HH; Liu G
    Yi Chuan; 2017 May; 39(5):355-367. PubMed ID: 28487268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.